Clinical Trial Update: Arachidonic Acid-induced Platelet Aggregation Rate in Patients With Stable CAD Treated With Ticagrelor Monotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating arachidonic acid–induced platelet aggregation in patients with stable coronary artery disease treated with ticagrelor monotherapy has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Yong Huo | Conditions: Coronary Heart Disease | Phase 4 | Status: COMPLETED